Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
暂无分享,去创建一个
E. Braunwald | C. Cannon | S. Murphy | W. Weintraub | N. Lakkis | N. Kleiman | P. Dibattiste | L. Demopoulos | Peter M Dibattiste
[1] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[2] E. Braunwald,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.
[3] L. Wallentin,et al. Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. , 2000, The American journal of cardiology.
[4] M. Galli. [Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[5] J. W. Schaeffer,et al. ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.
[6] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[7] L. Wallentin,et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.
[8] L. Wallentin. Low-Molecular-Weight Heparin as a Bridge to Timely Revascularization in Unstable Coronary Artery Disease – an Update of the Fragmin during Instability in Coronary Artery Disease II Trial , 2000, Pathophysiology of Haemostasis and Thrombosis.
[9] E W Steyerberg,et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.
[10] J. Zimmerman,et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. , 1999, Circulation.
[11] R. Califf,et al. Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion. , 1999, American heart journal.
[12] R. Califf,et al. Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia , 1998 .
[13] J. Saffitz,et al. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. , 1997, Clinical chemistry.
[14] H. Katus,et al. The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.
[15] R Roberts,et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. , 1990, Circulation.